application) The broad aim of this application is to train MD and PhD scientists for research careers in the field of molecular gastroenterology and hepatology. The University of Illinois at Chicago (UIC) has a critical mass of MD and PhD scientists whose Work focuses on diseases related to the gastrointestinal tract. This group of researchers is highly interactive and has formed a cohesive program identified as the Gastroenterology Interdisciplinary Research Group (GI-IRG). The members of this group have a distinguished record of training MD and PhD scientists in all aspects of investigative gastroenterology. Furthermore, GI-IRG scientists have recently attracted additional Federal funding to support junior faculty members during their transition from post-doctoral trainees to independent investigators. In contrast, no formal mechanism currently exists at our institution to support the training of MD and PhD post-doctoral trainees early after the receipt of their terminal degree. Within the GI-IRG exists a nucleus of twelve scientists who are well-funded, study clinical diseases at the bench, and are highly committed to educating fellows in molecular gastroenterology and hepatology. These individuals have an excellent record of developing clinically-oriented MDs into clinician-scientists, and training PhDs in molecular gastroenterology. All preceptors are members of the UIC Medical School faculty and are, either a part of, or are formally affiliated with, the UIC Section of Digestive and Liver Diseases. The training environment generated by the GI-IRG in general, and the Section of Digestive and Liver Diseases in particular, offers a rich mixture of seminars, visiting professors, and conferences that allows for stimulating exchanges between trainees and mentors. Training in molecular gastroenterology and hepatology is primarily within the laboratories of the faculty. Areas of expertise include: Ion Transport, Microbe-Gut Interactions, Differentiation/Oncology, and Liver Diseases/Hepatitis C. Laboratory work is supplemented with mandatory course work during the first year in Advanced GI Pathophysiology, the Molecular Basis of Growth and Differentiation, Applied Statistical Methods, and Strategies for Effective Scientific Communication. Trainees who complete this program will be eligible for continued support at UIC as junior faculty by virtue of another recently acquired Federal g

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
1T32DK007788-01
Application #
6149262
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
2000-08-15
Project End
2005-06-30
Budget Start
2000-08-15
Budget End
2001-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$53,210
Indirect Cost
Name
University of Illinois at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Halasi, Marianna; Hitchinson, Ben; Shah, Binal N et al. (2018) Honokiol is a FOXM1 antagonist. Cell Death Dis 9:84
Yazici, Cemal; Wolf, Patricia G; Kim, Hajwa et al. (2017) Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut 66:1983-1994
Bul, Vadim; Yazici, Cemal; Staudacher, Jonas J et al. (2017) Multiorgan Failure Predicts Mortality in Emphysematous Pancreatitis: A Case Report and Systematic Analysis of the Literature. Pancreas 46:825-830
Staudacher, Jonas J; Yazici, Cemal; Carroll, Timothy et al. (2017) Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target. Sci Rep 7:12786
Khan, I; Halasi, M; Zia, M F et al. (2017) Nuclear FOXM1 drives chemoresistance in AML. Leukemia 31:251-255
Halasi, Marianna; Váraljai, Renáta; Benevolenskaya, Elizaveta et al. (2016) A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS. J Biol Chem 291:142-8
Malecki, Elise A; Castellanos, Karla J; Cabay, Robert J et al. (2014) Therapeutic administration of orlistat, rosiglitazone, or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice. Pancreas 43:903-8
Yazici, Cemal; Niemeyer, David J; Iannitti, David A et al. (2014) Hepatocellular carcinoma and cholangiocarcinoma: an update. Expert Rev Gastroenterol Hepatol 8:63-82
Liu, Hongguang; Singla, Amika; Ao, Mei et al. (2011) Calcitonin receptor-mediated CFTR activation in human intestinal epithelial cells. J Cell Mol Med 15:2697-705
Tencate, Veronica; Sainz Jr, Bruno; Cotler, Scott J et al. (2010) Potential treatment options and future research to increase hepatitis C virus treatment response rate. Hepat Med 2010:125-145

Showing the most recent 10 out of 11 publications